Zevra Therapeutics (ZVRA) Interest Expenses (2014 - 2026)
Zevra Therapeutics (ZVRA) posted Interest Expenses of $1.71 million for Q1 2026, down 13.1% from $1.97 million a year earlier and down 12.2% from the prior quarter.
Zevra Therapeutics (ZVRA) Interest Expenses (2014 - 2026) Analysis & Trends
For FY2025, Zevra Therapeutics' Interest Expenses came in at $7.98 million, up 8.5% from FY2024.
- Annual Interest Expenses has increased for four consecutive years, with a five-year compound annual growth rate of 10.8% (FY2020 to FY2025).
- In prior years, Zevra Therapeutics' Interest Expenses was $7.35 million in FY2024 (+389.7%), $1.5 million in FY2023 (+348.1%), $335,000 in FY2022 (+48.2%) and $226,000 in FY2021 (-95.3%).
- The Q1 2026 figure stands as the lowest quarterly Interest Expenses since Q1 2024.
- On a year-over-year basis, Interest Expenses has declined in each of the last four quarters, with growth averaging 227.6% over the last eight quarters.
- The strongest year-over-year quarter for Interest Expenses in the past five years was Q2 2024, with growth of 971.1%; the weakest was Q4 2021, with a decline of 99.6%.
- According to Business Quant data, Interest Expenses for the three prior quarters was $1.95 million (Q4 2025), $2.05 million (Q3 2025) and $2.01 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Zevra Therapeutics | 650.98 Mn | -161.73 Mn | 38.18 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.71 Mn |
| Dec 31, 2025 | 1.95 Mn |
| Sep 30, 2025 | 2.05 Mn |
| Jun 30, 2025 | 2.01 Mn |
| Mar 31, 2025 | 1.97 Mn |
| Dec 31, 2024 | 2.19 Mn |
| Sep 30, 2024 | 2.31 Mn |
| Jun 30, 2024 | 2.11 Mn |
| Mar 31, 2024 | 735,000.00 |
| Dec 31, 2023 | 756,000.00 |
| Sep 30, 2023 | 366,000.00 |
| Jun 30, 2023 | 197,000.00 |
| Mar 31, 2023 | 182,000.00 |
| Dec 31, 2022 | 170,000.00 |
| Sep 30, 2022 | 124,000.00 |
| Jun 30, 2022 | 36,000.00 |
| Mar 31, 2022 | 5,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 6,000.00 |
| Jun 30, 2021 | 16,000.00 |
Zevra Therapeutics Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-expenses&ticker=ZVRA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-expenses", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=interest-expenses&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();